POU2F3 (also known as SKN-1a/OCT-11) has been recently identified as a novel marker expressed in and essential for the viability of ~10–12% of SCLC, which is strongly associated with tumors that have low or negative expression of the standard NE markers64,66. The gene discussed is POU2F3; the disease is small cell lung carcinoma.